However, the results of this study validate those from studies of clinical endpoints by using the subclinical outcome of CAC, thereby demonstrating that the Hp genotype is a robust biomarker for atherosclerosis in individuals with type 1 diabetes. This evidence concerns the gene HP and type 1 diabetes mellitus.